Medicamen Biotech Limited (MEDICAMEQ.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.98B |
| Enterprise Value | 3.15B |
| P/E Ratio | 39.83 |
| PEG Ratio | 1.76 |
| Price/Sales Ratio | 2.14 |
| Price/Book Ratio | 1.57 |
| Enterprise/Revenue | 2.14 |
| Enterprise/EBITDA | 20.21 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.05 |
| Operating Margin | 0.06 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 1.98B |
| Revenue/Share | 149.4 |
| Gross Profit | 540.86M |
| EBITDA | 227M |
| Net Income | 96.41M |
| Diluted EPS | 7.22 |
Balance Sheet
| Total Cash | 312.64M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 203.17 |
Price History
| 52-Week Change | 3.59 |
| 52-Week High | 447.65 |
| 52-Week Low | 212.4 |
| Moving Average 50 Days | 269.34 |
| Moving Average 200 Days | 284.01 |
Statistics
| Average Volume | 47,980 |
| Shares Outstanding | 13.56M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 0.31 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
